AIM:CRW

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. More Details


Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.


Similar Companies

Share Price & News

How has Craneware's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CRW is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: CRW's weekly volatility (7%) has been stable over the past year.


Market Performance


7 Day Return

17.6%

CRW

7.4%

GB Healthcare Services

1.2%

GB Market


1 Year Return

-10.4%

CRW

7.3%

GB Healthcare Services

-9.6%

GB Market

Return vs Industry: CRW underperformed the UK Healthcare Services industry which returned 7.3% over the past year.

Return vs Market: CRW underperformed the UK Market which returned -9.1% over the past year.


Shareholder returns

CRWIndustryMarket
7 Day17.6%7.4%1.2%
30 Day41.9%12.2%8.6%
90 Day30.2%6.9%5.4%
1 Year-8.5%-10.4%9.4%7.3%-6.1%-9.6%
3 Year57.8%52.2%31.8%24.4%-0.6%-12.6%
5 Year191.7%172.4%31.2%19.5%23.3%-4.4%

Long-Term Price Volatility Vs. Market

How volatile is Craneware's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Craneware undervalued compared to its fair value and its price relative to the market?

46.54x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: CRW (£22) is trading above our estimate of fair value (£7.14)

Significantly Below Fair Value: CRW is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: CRW is poor value based on its PE Ratio (46.5x) compared to the XE Healthcare Services industry average (43.2x).

PE vs Market: CRW is poor value based on its PE Ratio (46.5x) compared to the UK market (20.1x).


Price to Earnings Growth Ratio

PEG Ratio: CRW is poor value based on its PEG Ratio (19.1x)


Price to Book Ratio

PB vs Industry: CRW is overvalued based on its PB Ratio (11.4x) compared to the GB Healthcare Services industry average (4.8x).


Next Steps

Future Growth

How is Craneware forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

2.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRW's forecast earnings growth (2.4% per year) is above the savings rate (1.2%).

Earnings vs Market: CRW's earnings (2.4% per year) are forecast to grow slower than the UK market (26.7% per year).

High Growth Earnings: CRW's earnings are forecast to grow, but not significantly.

Revenue vs Market: CRW's revenue (6.4% per year) is forecast to grow slower than the UK market (6.4% per year).

High Growth Revenue: CRW's revenue (6.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CRW's Return on Equity is forecast to be low in 3 years time (19.4%).


Next Steps

Past Performance

How has Craneware performed over the past 5 years?

11.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CRW has a high level of non-cash earnings.

Growing Profit Margin: CRW's current net profit margins (23.5%) are higher than last year (21%).


Past Earnings Growth Analysis

Earnings Trend: CRW's earnings have grown by 11.3% per year over the past 5 years.

Accelerating Growth: CRW's earnings growth over the past year (12.3%) exceeds its 5-year average (11.3% per year).

Earnings vs Industry: CRW earnings growth over the past year (12.3%) exceeded the Healthcare Services industry -14.6%.


Return on Equity

High ROE: CRW's Return on Equity (24.6%) is considered high.


Next Steps

Financial Health

How is Craneware's financial position?


Financial Position Analysis

Short Term Liabilities: CRW's short term assets ($68.9M) exceed its short term liabilities ($45.3M).

Long Term Liabilities: CRW's short term assets ($68.9M) exceed its long term liabilities ($2.0M).


Debt to Equity History and Analysis

Debt Level: CRW is debt free.

Reducing Debt: CRW has not had any debt for past 5 years.

Debt Coverage: CRW has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: CRW has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Craneware current dividend yield, its reliability and sustainability?

1.15%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: CRW's dividend (1.15%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.72%).

High Dividend: CRW's dividend (1.15%) is low compared to the top 25% of dividend payers in the UK market (4.91%).


Stability and Growth of Payments

Stable Dividend: CRW's dividends per share have been stable in the past 10 years.

Growing Dividend: CRW's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (53.4%), CRW's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: CRW's dividends in 3 years are forecast to be well covered by earnings (47.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

9.8yrs

Average management tenure


CEO

Keith Neilson (51 yo)

21.83yrs

Tenure

US$390,225

Compensation

Mr. Keith Neilson co-founded Craneware PLC in 1999 and has served as its Chief Executive Officer ever since. Keith’s direction has helped Craneware to win multiple prestigious awards in such areas as inter...


CEO Compensation Analysis

Compensation vs Market: Keith's total compensation ($USD390.23K) is below average for companies of similar size in the UK market ($USD1.04M).

Compensation vs Earnings: Keith's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Keith Neilson
Co-Founder21.83yrsUS$390.23k12.9%
$ 75.2m
Craig Preston
CFO, Company Secretary & Executive Director12.17yrsUS$317.84k0.32%
$ 1.9m
Derek Paterson
Chief Information Officer20.17yrsno data0%
$ 0
Eric Carter
Chief Legal Officer3.08yrsno datano data
Seth Droe
Executive Vice President of Sales7.5yrsno datano data
Mark Montgomery
Chief Marketing Officer7.17yrsno datano data
Issy Urquhart
Chief People Officer4.92yrsno datano data
Karen Bowden
Executive Vice President of Customer Management19.83yrsno datano data

9.8yrs

Average Tenure

51yo

Average Age

Experienced Management: CRW's management team is seasoned and experienced (9.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Keith Neilson
Co-Founder21.83yrsUS$390.23k12.9%
$ 75.2m
Craig Preston
CFO, Company Secretary & Executive Director12.17yrsUS$317.84k0.32%
$ 1.9m
Ronald Verni
Senior Independent Non-Executive Directorno dataUS$60.71k0.0041%
$ 24.1k
Russ Rudish
Independent Non-Executive Director6.25yrsUS$52.64k0.0041%
$ 24.1k
William Whitehorn
Chairman of the Board0.83yrUS$47.24k0.0044%
$ 25.8k
Colleen Blye
Independent Non-Executive Director7yrsUS$61.60k0.0021%
$ 12.0k
David Kemp
Independent Non-Executive Director0.67yrUS$17.51kno data
Alistair Erskine
Independent Non-Executive Director0.75yrUS$14.68kno data

3.5yrs

Average Tenure

55.5yo

Average Age

Experienced Board: CRW's board of directors are considered experienced (3.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Craneware plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Craneware plc
  • Ticker: CRW
  • Exchange: AIM
  • Founded: 1999
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: UK£582.794m
  • Shares outstanding: 26.49m
  • Website: https://public.craneware.com

Number of Employees


Location

  • Craneware plc
  • 1 Tanfield
  • Edinburgh
  • EH3 5DA
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CRWAIM (London Stock Exchange AIM Market)YesOrdinary SharesGBGBPSep 2007
CRWR.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDSep 2007

Biography

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Tool...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/22 22:00
End of Day Share Price2020/11/20 00:00
Earnings2020/06/30
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.